I agree that this site is using cookies. You can find further informations here.
X
Hasanov, Elshad
32  results:
Search for persons X
?
1

Immune Checkpoint Therapy Combinations in Adult Advanced Mi..:

Alhalabi, Omar ; Thouvenin, Jonathan ; Négrier, Sylvie...
The Oncologist.  28 (2023)  5 - p. 433-439 , 2023
Link: https://doi.org/10.1093/..
 
?
2

Advances in non‐clear cell renal cell carcinoma management:..:

Wilson, Nathaniel R. ; Acikgoz, Yusuf ; Hasanov, Elshad
International Journal of Cancer.  154 (2023)  6 - p. 947-961 , 2023
Link: https://doi.org/10.1002/..
 
?
3

STARLITE 1: Phase 1b/2 study of combination 177Lu girentuxi..:

Hasanov, Elshad ; Flynt, Lesley ; Slack Tidwell, Rebecca...
The Oncologist.  28 (2023)  Supplement_1 - p. S13-S13 , 2023
Link: https://doi.org/10.1093/..
 
?
4

An interdisciplinary consensus on the management of brain m..:

Hasanov, Elshad ; Yeboa, Debra Nana ; Tucker, Mathew D....
CA: A Cancer Journal for Clinicians.  72 (2022)  5 - p. 454-489 , 2022
Link: https://doi.org/10.3322/..
 
?
5

Serum IGF-1 Scores and Clinical Outcomes in the Phase III I..:

Kaseb, Ahmed O ; Guan, Yinghui ; Gok Yavuz, Betul...
Journal of Hepatocellular Carcinoma.  9 (2022)  - p. 1065-1079 , 2022
Link: https://doi.org/10.2147/..
 
?
6

Efficacy of Cabozantinib in Metastatic MiT Family Transloca..:

Thouvenin, Jonathan ; Alhalabi, Omar ; Carlo, Maria...
The Oncologist.  27 (2022)  12 - p. 1041-1047 , 2022
Link: https://doi.org/10.1093/..
 
?
7

Outcomes of changing systemic therapy in patients with rela..:

Alhalabi, Omar ; Soomro, Zaid ; Sun, Ryan...
npj Breast Cancer.  7 (2021)  1 - p. , 2021
Link: https://doi.org/10.1038/..
 
?
8

Outcomes of patients with intermediate‐risk or poor‐risk me..:

Alhalabi, Omar ; Hasanov, Elshad ; Wilson, Nathaniel R....
International Journal of Cancer.  149 (2021)  2 - p. 387-393 , 2021
Link: https://doi.org/10.1002/..
 
?
9

Current Landscape and Future Directions of Biomarkers for I..:

Gok Yavuz, Betul ; Hasanov, Elshad ; Lee, Sunyoung S...
Journal of Hepatocellular Carcinoma.  8 (2021)  - p. 1195-1207 , 2021
Link: https://doi.org/10.2147/..
 
?
10

Phase II Study of Carfilzomib in Patients With Refractory R..:

Hasanov, Elshad ; Tidwell, Rebecca S.S. ; Fernandez, Pablo...
Clinical Genitourinary Cancer.  17 (2019)  6 - p. 451-456 , 2019
Link: https://doi.org/10.1016/..
 
?
11

Everolimus‐induced pneumonitis: A diagnostic challenge:

Gulde, Andrew ; Hasanov, Elshad ; Krug, Kayla.
The Breast Journal.  26 (2019)  2 - p. 287-288 , 2019
Link: https://doi.org/10.1111/..
 
?
12

Diffuse Large B-cell Lymphoma Masquerading as STEMI:

Hasanov, Elshad ; Marah, Naddi B. ; Rodriguez, Joe John..
Clinical Lymphoma Myeloma and Leukemia.  18 (2018)  - p. S293 , 2018
Link: https://doi.org/10.1016/..
 
?
13

Bleeding Challenge in Waldenström Macroglobulinemia:

Hasanov, Merve ; Hasanov, Elshad ; Hernandez, Cristhiam Rojas
Clinical Lymphoma Myeloma and Leukemia.  18 (2018)  - p. S246-S247 , 2018
Link: https://doi.org/10.1016/..
 
?
14

Pilot study of dovitinib in patients with von Hippel-Lindau..:

Pilié, Patrick ; Hasanov, Elshad ; Matin, Surena F....
Oncotarget.  9 (2018)  34 - p. 23390-23395 , 2018
Link: https://doi.org/10.18632..
 
?
15

Constıtutıonal and legal basıs for foundatıon and actıvıtıe..:

Hasanov, Elshad Eldar oqlu
LAPLAGE EM REVISTA.  7 (2021)  3C - p. 595-606 , 2021
Link: https://doi.org/10.24115..
 
1-15